Merrimack Provides Business Update and Reports 2017 Financial Results

March 12, 2018

Responsive image

CAMBRIDGE, Mass., March 12, 2018 /PRNewswire/ — Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a clinical-stage oncology company focused on biomarker-defined cancers, today announced its fourth quarter and full year 2017 financial results for the period ended December 31, 2017….

Category: Precious Metals